News from °µÍřTV Langone Health
Study Uncovers Older Adults Face Longer ER Wait Times At Hospitals. (Independent (UK))
(7/1) Boston physicians have found that the average length of stay and boarding times for patients over 65 in emergency rooms have significantly increased from 2017 to 2024, highlighting systemic healthcare challenges, with Ula Hwang, MD, MPH, professor, the Ronald O. Perelman Department of Emergency Medicine, and Population Health, telling the American Heart Association in May, “You really don’t want an 85-year-old or older patient lingering and sort of stranded in the emergency department for hours and days on end,” adding that it has “been shown that if you’re an older adult and you board in the emergency department overnight, you are at greater risk for developing delirium, even potentially having an inpatient mortality.”
Mortalities From America’s Top Cause Of Death Have Dropped 66 Percent – Study. (Newsweek)
(6/25) A study published in the Journal of the American Heart Association reveals a 66% drop in U.S. heart disease mortality over five decades, attributed to advancements in treating acute myocardial infarctions, while highlighting a rise in chronic heart conditions, with Glenn I. Fishman, MD, the William Goldring Professor of Medicine, Department of Medicine, professor, Departments of Biochemistry and Neuroscience, and vice chair, Research Department of Medicine, saying “emergent treatments to rapidly open coronary blockages and restore blood flow, or to address lethal cardiac arrhythmias, have markedly diminished sudden cardiac death,” while also noting, “a consequence of these life-saving interventions is a growing cadre of individuals, including aging patients, who develop more chronic forms of heart disease, such as ischemic cardiomyopathy or hypertensive heart disease – both of which can progress to heart failure.”
The Best Time To Eat Dinner For Your Health, According To Science. (Health)
(7/1) Discussing recommended timing for eating dinner, Collin J. Popp, PhD, assistant professor, Department of Population Health, said people should try to eat dinner between 5:00 p.m. and 7:00 p.m.
Moms Need Medicaid, Don’t Roll It Back. (New York Daily News)
The (7/2) Natasha J. Williams, EdD, MPH, associate professor, Department of Population Health, opposes Medicaid cuts as they pertain to pregnant women and mothers.
Dr Pothuri On Current Unmet Needs In Recurrent/Advanced Endometrial Cancer. (OncLive)
(7/1) Bhavana Pothuri, MD, professor, Department of Obstetrics and Gynecology, and Department of Medicine, Division of Hematology and Medical Oncology, Perlmutter Cancer Center, discusses unmet needs for patients with recurrent and advanced endometrial cancer.
OncLive’s FDA Approval Report: The Regulatory Rundown For June 2025. (OncLive)
(7/1) William C. Huang, MD, vice chair, clinical affairs, professor, Departments of Urology and Radiology, chief, urology service, Perlmutter Cancer Center, discussed the clinical significance of the FDA’s approval of “mitomycin intravesical solution (Zusduri; UGN-102) for the treatment of adult patients with recurrent, low-grade, intermediate-risk, non–muscle-invasive bladder cancer (NMIBC).”
National Psoriasis Foundation Tops $1.5 Million Fundraising Goal With Commit To Cure Gala. (Healio)
(7/1) The National Psoriasis Foundation raised over $1.5 million at its annual Commit to Cure gala on June 18 in New York City, honoring individuals for their contributions to psoriatic disease research and advocacy, including Jose U. Scher, MD, the Steere Abramson Professor of Medicine, Department of Medicine, Division of Rheumatology.
Startup Pi Health Built A Hospital In India To Test Its AI Software. (Forbes)
(7/1) Pi Health opened a 30-bed cancer hospital in Hyderabad, India, in September 2023, to expedite clinical trials using its AI-enabled software, which has already facilitated a significant drug approval in India and is now being deployed in 17 oncology centers globally, including partnerships with community clinics in the U.S. such as the Iyengar Hematology Oncology Center, run by Arjun Iyengar, MD, clinical assistant professor, Department of Medicine.
PROs Affirm Zongertinib’s Combination Of Strong Response Rates With Low Toxicity. (American Journal of Managed Care)
(7/1) Joshua K. Sabari, MD, assistant professor, Department of Medicine, Division of Hematology and Medical Oncology, Perlmutter Cancer, discussed the results of the phase 1a/1b Beamion LUNG-1 trial for zongertinib in patients with previously treated HER2-mutated non–small cell lung cancer at the annual meeting of the American Society of Clinical Oncology (ASCO) in Chicago, and stated “Zongertinib is a very clean medicine,” adding it is “a very well-tolerated oral therapy.1,2 So it’s the response together with the improvement in quality of life that is important.”
News from °µÍřTV Langone Hospital—Brooklyn
Cardiologists On The Move In The 1st Half Of 2025. (Becker's ASC Review)
The (7/1) °µÍřTV Langone Hospital-Brooklyn has named Noritsugu Naito, MD, PhD, clinical associate professor, Department of Cardiothoracic Surgery, and chief, Cardiac Surgery—Brooklyn as its first chief of cardiac surgery.
